OncoCyte Corporation (OCX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:49AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 33.68M |
| Enterprise value | 27.12M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 12.85 |
| Price/book (mrq) | 1.65 |
| Enterprise value/revenue | 18.04 |
| Enterprise value/EBITDA | -1.17 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.78 |
| 52-week change 3 | -52.89% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 5.8800 |
| 52-week low 3 | 2.0800 |
| 50-day moving average 3 | 2.8817 |
| 200-day moving average 3 | 3.1902 |
Share statistics
| Avg vol (3-month) 3 | 57.8k |
| Avg vol (10-day) 3 | 49.86k |
| Shares outstanding 5 | 13.34M |
| Implied shares outstanding 6 | 13.34M |
| Float 8 | 3.54M |
| % held by insiders 1 | 20.64% |
| % held by institutions 1 | 86.16% |
| Shares short (15 Apr 2024) 4 | 233.13k |
| Short ratio (15 Apr 2024) 4 | 1.77 |
| Short % of float (15 Apr 2024) 4 | 2.44% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.75% |
| Shares short (prior month 15 Mar 2024) 4 | 178.28k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 25 Jul 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,610.83% |
Management effectiveness
| Return on assets (ttm) | -15.91% |
| Return on equity (ttm) | -76.26% |
Income statement
| Revenue (ttm) | 1.5M |
| Revenue per share (ttm) | 0.20 |
| Quarterly revenue growth (yoy) | 14.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -20.59M |
| Net income avi to common (ttm) | -25.8M |
| Diluted EPS (ttm) | -3.3700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 9.43M |
| Total cash per share (mrq) | 1.14 |
| Total debt (mrq) | 2.87M |
| Total debt/equity (mrq) | 11.21% |
| Current ratio (mrq) | 1.49 |
| Book value per share (mrq) | 2.48 |
Cash flow statement
| Operating cash flow (ttm) | -23.32M |
| Levered free cash flow (ttm) | -6.9M |
© 2024 Yahoo. All rights reserved.